gian luca forni
gian luca forni
Medico, Ospedale Galliera, Genova
Email verificata su
Citata da
Citata da
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine
C Borgna-Pignatti, S Rugolotto, P De Stefano, H Zhao, MD Cappellini, ...
haematologica 89 (10), 1187-1193, 2004
Cardiac morbidity and mortality in deferoxamine-or deferiprone-treated patients with thalassemia major
C Borgna-Pignatti, MD Cappellini, P De Stefano, GC Del Vecchio, ...
Blood 107 (9), 3733-3737, 2006
Survival and complications in thalassemia
C BORGNA‐PIGNATTI, MD Cappellini, P De Stefano, GC Del Vecchio, ...
Annals of the New York Academy of Sciences 1054 (1), 40-47, 2005
On T2* magnetic resonance and cardiac iron
JP Carpenter, T He, P Kirk, M Roughton, LJ Anderson, SV de Noronha, ...
Circulation 123 (14), 1519-1528, 2011
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with …
A Piga, R Galanello, GL Forni, MD Cappellini, R Origa, A Zappu, ...
haematologica 91 (7), 873-880, 2006
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease
E Vichinsky, O Onyekwere, J Porter, P Swerdlow, J Eckman, P Lane, ...
British journal of haematology 136 (3), 501-508, 2007
Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study
J Porter, R Galanello, G Saglio, EJ Neufeld, E Vichinsky, MD Cappellini, ...
European journal of haematology 80 (2), 168-176, 2008
Hepatocellular carcinoma in the thalassaemia syndromes
C Borgna‐Pignatti, G Vergine, T Lombardo, MD Cappellini, P Cianciulli, ...
British journal of haematology 124 (1), 114-117, 2004
Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major
R Galanello, A Piga, GL Forni, Y Bertrand, ML Foschini, E Bordone, ...
haematologica 91 (10), 1343-1351, 2006
The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1—a meta-analysis of 15 prospective cohort studies
International Perinatal HIV Group
New England Journal of Medicine 340 (13), 977-987, 1999
Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies
G Derchi, GL Forni, F Formisano, MD Cappellini, R Galanello, G D'Ascola, ...
Haematologica 90 (4), 452-458, 2005
Pregnancy and β-thalassemia: an Italian multicenter experience
R Origa, A Piga, G Quarta, GL Forni, F Longo, A Melpignano, R Galanello
haematologica 95 (3), 376-381, 2010
Onset of clinical signs in children with HIV-1 perinatal infection. Italian Register for HIV Infection in Children.
L Galli, M de Martino, PA Tovo, C Gabiano, M Zappa, C Giaquinto, ...
AIDS (London, England) 9 (5), 455-461, 1995
Prognostic significance of immunologic changes in 675 infants perinatally exposed to human immunodeficiency virus
M de Martino, PA Tovo, L Galli, C Gabiano, S Cozzani, C Gotta, G Scarlatti, ...
The Journal of pediatrics 119 (5), 702-709, 1991
Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts
V Positano, A Pepe, MF Santarelli, B Scattini, D De Marchi, A Ramazzotti, ...
NMR in Biomedicine: An International Journal Devoted to the Development and …, 2007
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation
G Abbruzzese, G Cossu, M Balocco, R Marchese, D Murgia, M Melis, ...
Haematologica 96 (11), 1708-1711, 2011
Mode of delivery and gestational age influence perinatal HIV-1 transmission
PA Tovo, M De Martino, C Gabiano, L Galli, N Cappello, E Ruga, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 11 (1), 88-94, 1996
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
RDC Heeney MM, Hoppe CC, Abboud MR, Inusa B, Kanter J, Ogutu B, Brown PB ...
N Engl J Med. [Epub ahead of print], 2016
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
RDC Heeney MM, Hoppe CC, Abboud MR, Inusa B, Kanter J, Ogutu B, Brown PB ...
Genetic and clinical heterogeneity of ferroportin disease
L Cemonesi, GL Forni, N Soriani, M Lamagna, I Fermo, F Daraio, A Galli, ...
British journal of haematology 131 (5), 663-670, 2005
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20